The munKNEE "Rags-to-Riches" Portfolio consists of 16 cannabis, psychedelic, and plant-based food stocks with market capitalizations between $400M and...
The article Chrisitian Angermayer Shows Faith in Atai, Buys Another 1.2 M Shares was originally published on Microdose. On March 29th, Christian Angermayer,...
The munKNEE Psychedelic Drug Stocks Index was DOWN 3.4% in March but is still UP 1.2% YTD and the average price targets of the above stocks represent...
Compared to other psychedelic conferences, ECNP was a dose of European realism - from the anticipated effect sizes of psychedelic trials to the cut and...
SAINT LAURENT, Quebec, March 29, 2023 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today reported...
The article Atai CEO Answers Questions From the Public was originally published on Microdose. Reddit is the internet incarnate. From time-wasting memes,...
MD legal sales vote; OR interstate marijuana commerce suit; NV psychedelics; Canada dispensary study; Congressman: protect patients from pesticides Subscribe to...
With uncertainty in the financial systems, many psychedelic companies are seeing their stock prices plummet. The post It’s Survival of the Fittest among...
The company spent more money on research and cut down on overhead costs. The post Atai Life Sciences Losses Shrunk in 2022 Amid Restructuring Bid appeared...
atai’s development candidates, such as RL-007 and GRX-917, all represent significant opportunities to address unmet medical needs of patients living...